Toripalimab Combined With Anthracycline-free or Anthracycline-containing Chemotherapy as Neoadjuvant Chemotherapy for Early Triple Negative Breast Cancer

NCT07256964 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

216

Enrollment

OTHER_GOV

Sponsor class

Conditions

TNBC - Triple-Negative Breast Cancer

Interventions

DRUG: Toripalimab
DRUG: PCb-EC
DRUG: PCb

Sponsor

Henan Cancer Hospital